Similar articles

• Failure of tenofovir + abacavir + 3TC combination; full report published, more insight.

  James JS. James JS. AIDS Treat News. 2005 Oct-Nov;(416):5-6. AIDS Treat News. 2005. PMID: 16388545
• Safety and efficacy of tenofovir/emtricitabine or abacavir/lamivudine in combination with efavirenz in treatment naïve HIV patients: a 5 year retrospective observational cohort study. (the TOKEN Study).

  Pammi M, Arumainayagam J, Kumari B, Ahmed-Jushuf I, Carlin EM, Chandramani S, Riddell L, Ghanem M, Das S. Pammi M, et al. Int J Clin Pract. 2013 Sep;67(9):922-3. doi: 10.1111/ijcp.12233. Int J Clin Pract. 2013. PMID: 23952469 No abstract available.
• Long-term follow-up of patients with initial early virologic failure after being treated with once-daily tenofovir/abacavir/lamivudine.

  Khanlou H, Farthing C. Khanlou H, et al. AIDS Patient Care STDS. 2006 Sep;20(9):604-5. doi: 10.1089/apc.2006.20.604. AIDS Patient Care STDS. 2006. PMID: 16987045 No abstract available.
• Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV.

  Stürmer M, Staszewski S, Doerr HW. Stürmer M, et al. Antivir Ther. 2007;12(5):695-703. Antivir Ther. 2007. PMID: 17713153 Review.
• Experience with tenofovir disoproxil fumarate for antiretroviral therapy.

  Stephan C. Stephan C. Expert Opin Pharmacother. 2008 May;9(7):1197-209. doi: 10.1517/14656566.9.7.1197. Expert Opin Pharmacother. 2008. PMID: 18422476 Review.